| abstract |
The invention relates to a pharmaceutical preparation for a topical/oral application on the mucous membranes in the oral, nasal, and/or pharyngeal cavity, comprising at least the components a) 0.01 to 0.7 wt.% of a corticoid, b) 0.01 to 5 wt.% of a metal compound, c) 0.01 to 5 wt.% of an adstringen, d) 0.005 to 0.03 wt.% of a disinfectant, and e) 0.01 to 0.06 wt.% of a hyaluronic acid, wherein the preparation is supplemented to 100 wt.% with a pharmaceutically acceptable solvent. The invention further relates to the use of the preparation for the therapy of laryngitis, in particular a viral laryngitis. |